NAFLD has become a major public health problem for more than 2 decades with a growing
prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease …

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions that
are characterized by excess accumulation of fat in the liver, and is diagnosed after exclusion …

Non-alcoholic fatty liver disease (NAFLD) is a definition of a prevalent condition that has
been given a name describing what the disease is not, mainly due to gaps in the …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

The map and global disease burden of chronic liver diseases are markedly changing, with
nonalcoholic fatty liver disease (NAFLD) becoming the most common cause of liver …

IMPORTANCE The diagnostic performance of the fibrosis-4 index (FIB-4) and nonalcoholic
fatty liver disease (NAFLD) fibrosis score (NFS) for advanced fibrosis in lean patients with …

Objective Clinical diagnosis and approval of new medications for non-alcoholic
steatohepatitis (NASH) require invasive liver biopsies. The aim of our study was to identify …

Metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, and non-
alcoholic fatty liver disease (NAFLD)–henceforth named metabolic dysfunction-associated …

Non-alcoholic fatty liver disease occurring in non-obese subjects (the so-called non-obese
NAFLD) is a highly prevalent but neglected liver condition, which is closely associated with …

Nonalcoholic fatty liver disease (NAFLD) affects at least 25% of the global adult population
and is one of the leading causes of cirrhosis and hepatocellular carcinoma (HCC) in western …